1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Autotransfusion Devices Market
4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution/Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Autotransfusion Devices Market Analysis and Forecast, 2017–2031
5. Key Insights
    5.1. Pipeline Analysis
    5.2. Key Product/Brand Analysis
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry
6. Global Autotransfusion Devices Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product Type, 2017–2031
        6.3.1. On-pump Transfusion Device
        6.3.2. Off-pump Transfusion Device
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Autotransfusion Devices Market Analysis and Forecast, by End-user
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by End-user, 2017–2031
        7.3.1. Hospitals
        7.3.2. Ambulatory Surgical Centers
        7.3.3. Cardiac Research Centers
    7.4. Market Attractiveness Analysis, by End-user
8. Global Autotransfusion Devices Market Analysis and Forecast, by Region
    8.1. Key Findings
    8.2. Market Value Forecast, by Region, 2017–2031
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Market Attractiveness Analysis, by Region
9. North America Autotransfusion Devices Market Analysis and Forecast
    9.1. Introduction
    9.2. Key Findings
    9.3. Market Value Forecast, by Product Type, 2017–2031
        9.3.1. On-pump Transfusion Device
        9.3.2. Off-pump Transfusion Device
    9.4. Market Value Forecast, by End-user, 2017–2031
        9.4.1. Hospitals
        9.4.2. Ambulatory Surgical Centers
        9.4.3. Cardiac Research Centers
    9.5. Market Value Forecast, by Country, 2017–2031
        9.5.1. U.S.
        9.5.2. Canada
    9.6. Market Attractiveness Analysis
        9.6.1. By Product Type
        9.6.2. By End-user
        9.6.3. By Country
10. Europe Autotransfusion Devices Market Analysis and Forecast
    10.1. Introduction
    10.2. Key Findings
    10.3. Market Value Forecast, by Product Type, 2017–2031
        10.3.1. On-pump Transfusion Device
        10.3.2. Off-pump Transfusion Device
    10.4. Market Value Forecast, by End-user, 2017–2031
        10.4.1. Hospitals
        10.4.2. Ambulatory Surgical Centers
        10.4.3. Cardiac Research Centers
    10.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        10.5.1. Germany
        10.5.2. U.K.
        10.5.3. France
        10.5.4. Italy
        10.5.5. Spain
        10.5.6. Rest of Europe
    10.6. Market Attractiveness Analysis
        10.6.1. By Product Type
        10.6.2. By End-user
        10.6.3. By Country/Sub-region
11. Asia Pacific Autotransfusion Devices Market Analysis and Forecast
    11.1. Introduction
    11.2. Key Findings
    11.3. Market Value Forecast, by Product Type, 2017–2031
        11.3.1. On-pump Transfusion Device
        11.3.2. Off-pump Transfusion Device
    11.4. Market Value Forecast, by End-user, 2017–2031
        11.4.1. Hospitals
        11.4.2. Ambulatory Surgical Centers
        11.4.3. Cardiac Research Centers
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. China
        11.5.2. Japan
        11.5.3. India
        11.5.4. Australia & New Zealand
        11.5.5. Rest of Asia Pacific
    11.6. Market Attractiveness Analysis
        11.6.1. By Product Type
        11.6.2. By End-user
        11.6.3. By Country/Sub-region
12. Latin America Autotransfusion Devices Market Analysis and Forecast
    12.1. Introduction
    12.2. Key Findings
    12.3. Market Value Forecast, by Product Type, 2017–2031
        12.3.1. On-pump Transfusion Device
        12.3.2. Off-pump Transfusion Device
    12.4. Market Value Forecast, by End-user, 2017–2031
        12.4.1. Hospitals
        12.4.2. Ambulatory Surgical Centers
        12.4.3. Cardiac Research Centers
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. Brazil
        12.5.2. Mexico
        12.5.3. Rest of Latin America
    12.6. Market Attractiveness Analysis
        12.6.1. By Product Type
        12.6.2. By End-user
        12.6.3. By Country/Sub-region
13. Middle East & Africa Autotransfusion Devices Market Analysis and Forecast
    13.1. Introduction
    13.2. Key Findings
    13.3. Market Value Forecast, by Product Type, 2017–2031
        13.3.1. On-pump Transfusion Device
        13.3.2. Off-pump Transfusion Device
    13.4. Market Value Forecast, by End-user, 2017–2031
        13.4.1. Hospitals
        13.4.2. Ambulatory Surgical Centers
        13.4.3. Cardiac Research Centers
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. GCC Countries
        13.5.2. South Africa
        13.5.3. Rest of Middle East & Africa
    13.6. Market Attractiveness Analysis
        13.6.1. By Product Type
        13.6.2. By End-user
        13.6.3. By Country/Sub-region
14. Competition Landscape
    14.1. Market Player – Competitive Matrix (by Tier and Size of Companies)
    14.2. Market Share Analysis, by Company (2022)
    14.3. Company Profiles
        14.3.1. Fresenius Kabi AG
            14.3.1.1. Company Overview
            14.3.1.2. Product Portfolio
            14.3.1.3. SWOT Analysis
            14.3.1.4. Financial Overview
            14.3.1.5. Strategic Overview
        14.3.2. Haemonetics Corporation
            14.3.2.1. Company Overview
            14.3.2.2. Product Portfolio
            14.3.2.3. SWOT Analysis
            14.3.2.4. Financial Overview
            14.3.2.5. Strategic Overview
        14.3.3. LivaNova PLC
            14.3.3.1. Company Overview
            14.3.3.2. Product Portfolio
            14.3.3.3. SWOT Analysis
            14.3.3.4. Financial Overview
            14.3.3.5. Strategic Overview
        14.3.4. Medtronic
            14.3.4.1. Company Overview
            14.3.4.2. Product Portfolio
            14.3.4.3. SWOT Analysis
            14.3.4.4. Financial Overview
            14.3.4.5. Strategic Overview
        14.3.5. Terumo Corporation
            14.3.5.1. Company Overview
            14.3.5.2. Product Portfolio
            14.3.5.3. SWOT Analysis
            14.3.5.4. Financial Overview
            14.3.5.5. Strategic Overview
        14.3.6. Stryker
            14.3.6.1. Company Overview
            14.3.6.2. Product Portfolio
            14.3.6.3. SWOT Analysis
            14.3.6.4. Financial Overview
            14.3.6.5. Strategic Overview
        14.3.7. Atrium Medical Technologies
            14.3.7.1. Company Overview
            14.3.7.2. Product Portfolio
            14.3.7.3. SWOT Analysis
            14.3.7.4. Financial Overview
            14.3.7.5. Strategic Overview
        14.3.8. Advancis Surgical
            14.3.8.1. Company Overview
            14.3.8.2. Product Portfolio
            14.3.8.3. SWOT Analysis
            14.3.8.4. Financial Overview
            14.3.8.5. Strategic Overview
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			